<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Esophageal Cancer

Research    Patient Care    Esophageal Cancer    Surgical Oncology    Clinical Trials

Investigating a Better Treatment Sequence for Esophageal Cancer

Looking for better ways to treat patients with esophageal cancer, University of Colorado Cancer Center member Martin McCarter, MD, is investigating whether a new treatment sequence will result in better outcomes.


Author Greg Glasgow | Publish Date May 25, 2021
Full Story

CU Cancer Center In the News

Healio

Animal imaging researcher wins award for contribution to oncology research

news outletHealio
Publish DateAugust 04, 2021

The International Society of Magnetic Resonance in Medicine awarded Natalie J. Serkova, the 2021 Senior Fellow Award for her work in animal imaging for oncology research. “I was humbled and ecstatic to receive this award…,” Serkova, director of the Animal Imaging Shared Resource at University of Colorado Cancer Center, said during an interview with Healio.

Full Story
Cure Today

Life With von Hippel-Lindau Disease

news outletCure Today
Publish DateAugust 03, 2021

At first, Camron King’s sixth-grade teacher thought he was nervous. King had just started at a new school when he told the teacher he couldn’t read aloud from his textbook. The problem, however, was more complicated than childhood stage fright.

Full Story
Denver Gazette

UCHealth ranked among top 50 hospitals nationally in 8 specialties

news outletDenver Gazette
Publish DateJuly 27, 2021

UCHealth ranked in the top 50 nationally for gastroenterology; ear, nose and throat care; adult diabetes and endocrinology; cancer treatment; urology; and rheumatology.

Full Story
OncLive

Dr. Pollyea on Indications for Anti-CD33 Therapy in AML

news outletOncLive
Publish DateJuly 19, 2021

Daniel Pollyea, MD, MS, associate professor of medicine/hematology, and the clinical director of Leukemia Services at the University of Colorado School of Medicine, discusses indications for anti-CD33 therapy in the treatment of patients with acute myeloid leukemia (AML).

Full Story